Kidney protection during heart surgery
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a treatment called RenalGuard to help protect your kidneys from damage that can happen after heart surgery. It may be helpful if you have certain risk factors like diabetes or kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You will be having a non-emergency heart surgery that uses a heart-lung machine (like a bypass or valve repair).
- You need to have at least one risk factor for kidney problems after surgery, such as kidney disease, diabetes, low heart function, or anemia.
- You cannot be on dialysis or have very poor kidney function (below a certain level).
- You cannot have had a contrast dye scan (like a CT) within 48 hours before your surgery.
- You cannot be pregnant, have an active infection, or have had major surgery in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a protein in the blood that may help predict kidney damage after heart surgery. It aims to find ways to protect kidney function during and after the operation.
This study looks at how heart surgery affects kidney function. It may help doctors better protect the kidneys during and after surgery.
This study looks at how your body's metabolism (energy use) can predict if you'll get kidney damage after heart surgery. It aims to help doctors identify high-risk patients earlier so they can prevent or treat kidney problems sooner.
This study looks at why some people develop kidney damage after heart surgery that uses a heart-lung machine. It aims to help doctors better predict and prevent this complication.
This study tests a new drug (ENN0403) given during heart surgery to see if it prevents acute kidney injury—a sudden drop in kidney function. The trial is for people who are already at higher risk due to their specific heart surgery and other health factors.
This trial tests a drug called SP16 to see if it can prevent acute kidney injury in people with chronic kidney disease who are having elective heart surgery with a heart-lung machine. It aims to help preserve kidney function after surgery.
Hear when a new Cardiac Surgery Associated - Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.